Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.47B |
| 2 |
NVIDIA
NVDA
|
+$1.15B |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
+$646M |
| 4 |
Moderna
MRNA
|
+$520M |
| 5 |
Qualcomm
QCOM
|
+$510M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Palo Alto Networks
PANW
|
+$482M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$431M |
| 5 |
Microsoft
MSFT
|
+$374M |
Sector Composition
| 1 | Technology | 24.56% |
| 2 | Financials | 14.36% |
| 3 | Healthcare | 11.73% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Cytosorbents Corp
CTSO
$59M
| $210K | ﹤0.01% |
50,051
+32,885
| +192% | +$138K |
|
|
PZN
2777
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $210K | ﹤0.01% |
22,124
+15,220
| +220% | +$144K |
|
|
AXDX
2778
DELISTED
Accelerate Diagnostics
AXDX
| $209K | ﹤0.01% |
4,004
+2,656
| +197% | +$139K |
|
2779
CorMedix
CRMD
$968M
| $209K | ﹤0.01% |
45,996
+30,509
| +197% | +$139K |
|
2780
Hamilton Beach Brands
HBB
$196M
| $209K | ﹤0.01% |
14,564
+5,978
| +70% | +$85.8K |
|
2781
Methanex
MEOH
$3.05B
| $209K | ﹤0.01% |
5,298
+4,492
| +557% | +$177K |
|
2782
LifeVantage
LFVN
$142M
| $207K | ﹤0.01% |
32,756
-1,709
| -5% | -$10.8K |
|
2783
Oil-Dri
ODC
$962M
| $207K | ﹤0.01% |
12,656
+8,394
| +197% | +$137K |
|
2784
XBiotech
XBIT
$85.4M
| $206K | ﹤0.01% |
18,484
+12,220
| +195% | +$136K |
|
|
ITI
2785
DELISTED
Iteris, Inc.
ITI
| $206K | ﹤0.01% |
51,411
+34,101
| +197% | +$137K |
|
|
ERUS
2786
DELISTED
iShares MSCI Russia ETF
ERUS
| $206K | ﹤0.01% |
4,802
+4,705
| +4,851% | +$202K |
|
2787
BeyondSpring
BYSI
$75.4M
| $204K | ﹤0.01% |
45,100
-128,098
| -74% | -$579K |
|
2788
Nathan's Famous
NATH
$444M
| $202K | ﹤0.01% |
3,453
+2,291
| +197% | +$134K |
|
2789
Silvercrest Asset Management
SAMG
$136M
| $202K | ﹤0.01% |
11,782
-1,447
| -11% | -$24.8K |
|
|
EIGR
2790
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $202K | ﹤0.01% |
1,295
+859
| +197% | +$134K |
|
2791
Icahn Enterprises
IEP
$4.75B
| $200K | ﹤0.01% |
4,038
-9,043
| -69% | -$448K |
|
2792
Carisma Therapeutics
CARM
$15.4M
| $199K | ﹤0.01% |
12,217
+8,055
| +194% | +$131K |
|
2793
Caledonia Mining Corp
CMCL
$636M
| $199K | ﹤0.01% |
17,076
+10,551
| +162% | +$123K |
|
|
BCEL
2794
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $199K | ﹤0.01% |
65,735
+33,480
| +104% | +$101K |
|
2795
Dianthus Therapeutics
DNTH
$1.18B
| $198K | ﹤0.01% |
2,793
+1,505
| +117% | +$107K |
|
2796
CB Financial Services
CBFV
$167M
| $197K | ﹤0.01% |
8,198
-477
| -5% | -$11.5K |
|
2797
Investar Holding Corp
ISTR
$224M
| $197K | ﹤0.01% |
10,705
-1,518
| -12% | -$27.9K |
|
|
RDHL
2798
Redhill Biopharma
RDHL
$3.56M
| $197K | ﹤0.01% |
+77
| New | +$197K |
|
2799
Genesis Energy
GEL
$2.01B
| $196K | ﹤0.01% |
18,301
-2,207
| -11% | -$23.6K |
|
2800
Gaotu Techedu
GOTU
$884M
| $196K | ﹤0.01% |
101,244
-77,900
| -43% | -$151K |
|